<!DOCTYPE html>
<html lang="en-us">
<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Source Themes Academic 4.1.0">
  <meta name="generator" content="Hugo 0.54.0" />

  

  
  
  
  
  
    
    
    
  
  

  <meta name="author" content="Martin J. Menten">

  
  
  
    
  
  <meta name="description" content="**Purpose:** This study investigates the feasibility and potential benefits of radiotherapy with a 1.5 T MR-Linac for locally advanced non-small cell lung cancer (LA NSCLC) patients.&lt;br/&gt; **Material and methods:** Ten patients with LA NSCLC were retrospectively re-planned six times: three treatment plans were created according to a protocol for conventionally fractionated radiotherapy and three treatment plans following guidelines for isotoxic target dose escalation. In each case, two plans were designed for the MR-Linac, either with standard (~7 mm) or reduced (~3 mm) planning target volume (PTV) margins, while one conventional linac plan was created with standard margins. Treatment plan quality was evaluated using dose–volume metrics or by quantifying dose escalation potential.&lt;br/&gt; **Results:** All generated treatment plans fulfilled their respective planning constraints. For conventionally fractionated treatments, MR-Linac plans with standard margins had slightly increased skin dose when compared to conventional linac plans. Using reduced margins alleviated this issue and decreased exposure of several other organs-at-risk (OAR). Reduced margins also enabled increased isotoxic target dose escalation.&lt;br/&gt; **Conclusions:** It is feasible to generate treatment plans for LA NSCLC patients on a 1.5 T MR-Linac. Margin reduction, facilitated by an envisioned MRI-guided workflow, enables increased OAR sparing and isotoxic target dose escalation for the respective treatment approaches.">

  
  <link rel="alternate" hreflang="en-us" href="/publication/ereps2/">

  


  

  

  

  

  

  

  
  
  
  <meta name="theme-color" content="#2962ff">
  

  
  
  
  
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/4.1.3/css/bootstrap.min.css" integrity="sha256-eSi1q2PG6J7g7ib17yAaWMcrr5GrtohYChqibrV7PBE=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css" integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.6.0/css/all.css" integrity="sha384-aOkxzJ5uQz7WBObEZcHvV5JvRW3TUc2rNPA7pe3AwnsUohiw1Vj2Rgx2KSOkF5+h" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.css" integrity="sha256-ygkqlh3CYSUri3LhQxzdcm0n1EQvH2Y+U5S2idbLtxs=" crossorigin="anonymous">

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/styles/github.min.css" crossorigin="anonymous" title="hl-light">
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/styles/dracula.min.css" crossorigin="anonymous" title="hl-dark" disabled>
        
      
    

    

    

  

  
  
  <link rel="stylesheet" href="//fonts.googleapis.com/css?family=Montserrat:400,700|Roboto:400,400italic,700|Roboto+Mono">
  

  <link rel="stylesheet" href="/styles.css">
  
    
    
    
    
      
    
    
    
    <link rel="stylesheet" href="/css/academic.e46c5d86875234f3d4d9a893b21aae0e.css">
  

  
  
  

  
  <link rel="alternate" href="/index.xml" type="application/rss+xml" title="Martin J. Menten">
  <link rel="feed" href="/index.xml" type="application/rss+xml" title="Martin J. Menten">
  

  <link rel="manifest" href="/site.webmanifest">
  <link rel="icon" type="image/png" href="/img/icon.png">
  <link rel="apple-touch-icon" type="image/png" href="/img/icon-192.png">

  <link rel="canonical" href="/publication/ereps2/">

  
  
  
  
    
  
  <meta property="twitter:card" content="summary_large_image">
  
  <meta property="og:site_name" content="Martin J. Menten">
  <meta property="og:url" content="/publication/ereps2/">
  <meta property="og:title" content="Treating locally advanced lung cancer with a 1.5 T MR-Linac – Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy | Martin J. Menten">
  <meta property="og:description" content="**Purpose:** This study investigates the feasibility and potential benefits of radiotherapy with a 1.5 T MR-Linac for locally advanced non-small cell lung cancer (LA NSCLC) patients.&lt;br/&gt; **Material and methods:** Ten patients with LA NSCLC were retrospectively re-planned six times: three treatment plans were created according to a protocol for conventionally fractionated radiotherapy and three treatment plans following guidelines for isotoxic target dose escalation. In each case, two plans were designed for the MR-Linac, either with standard (~7 mm) or reduced (~3 mm) planning target volume (PTV) margins, while one conventional linac plan was created with standard margins. Treatment plan quality was evaluated using dose–volume metrics or by quantifying dose escalation potential.&lt;br/&gt; **Results:** All generated treatment plans fulfilled their respective planning constraints. For conventionally fractionated treatments, MR-Linac plans with standard margins had slightly increased skin dose when compared to conventional linac plans. Using reduced margins alleviated this issue and decreased exposure of several other organs-at-risk (OAR). Reduced margins also enabled increased isotoxic target dose escalation.&lt;br/&gt; **Conclusions:** It is feasible to generate treatment plans for LA NSCLC patients on a 1.5 T MR-Linac. Margin reduction, facilitated by an envisioned MRI-guided workflow, enables increased OAR sparing and isotoxic target dose escalation for the respective treatment approaches."><meta property="og:image" content="/publication/ereps2/featured.jpg">
  <meta property="og:locale" content="en-us">
  
  <meta property="article:published_time" content="2017-11-01T00:00:00&#43;00:00">
  
  <meta property="article:modified_time" content="2017-11-01T00:00:00&#43;00:00">
  

  

  

  <title>Treating locally advanced lung cancer with a 1.5 T MR-Linac – Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy | Martin J. Menten</title>

</head>
<body id="top" data-spy="scroll" data-target="#TableOfContents" data-offset="71" >
  <aside class="search-results" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        
        
      </div>

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>


<nav class="navbar navbar-light fixed-top navbar-expand-lg py-0" id="navbar-main">
  <div class="container">

    
      <a class="navbar-brand" href="/">Martin J. Menten</a>
      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
        <span><i class="fas fa-bars"></i></span>
      </button>
      

    
    <div class="collapse navbar-collapse" id="navbar">

      
      
      <ul class="navbar-nav mr-auto">
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#banner">
            
            <span>Home</span>
            
          </a>
        </li>

        
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#publications">
            
            <span>Publications</span>
            
          </a>
        </li>

        
        

      

        

        

        

        

      </ul>

    </div>
  </div>
</nav>

<div class="pub" itemscope itemtype="http://schema.org/CreativeWork">

  













<div class="article-header d-xl-none">
  <div class="featured-image" style="background-image: url('/publication/ereps2/featured_hu38189f69cb2b4f9d1e35fd064ef94aa4_231582_800x0_resize_q90_lanczos.jpg');"></div>
  
</div>


<div class="container-fluid split-header d-none d-xl-block">
  <div class="row">
    <div class="col-6">
      <div class="split-header-content">
        <h2 itemprop="name">Treating locally advanced lung cancer with a 1.5 T MR-Linac – Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy</h2>

        

        



<meta content="2017-11-01 00:00:00 &#43;0000 GMT" itemprop="datePublished">
<meta content="2017-11-01 00:00:00 &#43;0000 GMT" itemprop="dateModified">

<div class="article-metadata">

  
  
  
  
  <div>
    



  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      HE Bainbridge</span></span>, 
  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      MJ Menten</span></span>, 
  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      MF Fast</span></span>, 
  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      S Nill</span></span>, 
  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      U Oelfke</span></span>, 
  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      F McDonald</span></span>
  



  </div>
  
  

  
  <span class="article-date">
    
    
      
    
    <time>November 2017</time>
  </span>
  

  

  

  
  

  

  

</div>


        







  






  



<div class="btn-links mb-3">
  
  







  
    
  


<a class="btn btn-outline-primary my-1 mr-1" href="/files/EREPS2.pdf" target="_blank" rel="noopener">
  PDF
</a>



<button type="button" class="btn btn-outline-primary my-1 mr-1 js-cite-modal"
        data-filename="/publication/ereps2/cite.bib">
  Cite
</button>













<a class="btn btn-outline-primary my-1 mr-1" href="https://doi.org/10.1016/j.radonc.2017.09.009" target="_blank" rel="noopener">
  DOI
</a>



</div>



        

      </div>
    </div>
    <div class="col-6">
      <div class="split-header-image">
        <img src="/publication/ereps2/featured.jpg" itemprop="image" alt="">
        
      </div>
    </div>
  </div>
</div>

<div class="article-container d-xl-none">
  <h1 itemprop="name">Treating locally advanced lung cancer with a 1.5 T MR-Linac – Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy</h1>

  

  



<meta content="2017-11-01 00:00:00 &#43;0000 GMT" itemprop="datePublished">
<meta content="2017-11-01 00:00:00 &#43;0000 GMT" itemprop="dateModified">

<div class="article-metadata">

  
  
  
  
  <div>
    



  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      HE Bainbridge</span></span>, 
  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      MJ Menten</span></span>, 
  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      MF Fast</span></span>, 
  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      S Nill</span></span>, 
  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      U Oelfke</span></span>, 
  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      F McDonald</span></span>
  



  </div>
  
  

  
  <span class="article-date">
    
    
      
    
    <time>November 2017</time>
  </span>
  

  

  

  
  

  

  
    

  

</div>

  







  






  



<div class="btn-links mb-3">
  
  







  
    
  


<a class="btn btn-outline-primary my-1 mr-1" href="/files/EREPS2.pdf" target="_blank" rel="noopener">
  PDF
</a>



<button type="button" class="btn btn-outline-primary my-1 mr-1 js-cite-modal"
        data-filename="/publication/ereps2/cite.bib">
  Cite
</button>













<a class="btn btn-outline-primary my-1 mr-1" href="https://doi.org/10.1016/j.radonc.2017.09.009" target="_blank" rel="noopener">
  DOI
</a>



</div>


</div>



  <div class="article-container">

    
    <h3>Abstract</h3>
    <p class="pub-abstract" itemprop="text"><strong>Purpose:</strong> This study investigates the feasibility and potential benefits of radiotherapy with a 1.5 T MR-Linac for locally advanced non-small cell lung cancer (LA NSCLC) patients.<br/> <strong>Material and methods:</strong> Ten patients with LA NSCLC were retrospectively re-planned six times: three treatment plans were created according to a protocol for conventionally fractionated radiotherapy and three treatment plans following guidelines for isotoxic target dose escalation. In each case, two plans were designed for the MR-Linac, either with standard (~7 mm) or reduced (~3 mm) planning target volume (PTV) margins, while one conventional linac plan was created with standard margins. Treatment plan quality was evaluated using dose–volume metrics or by quantifying dose escalation potential.<br/> <strong>Results:</strong> All generated treatment plans fulfilled their respective planning constraints. For conventionally fractionated treatments, MR-Linac plans with standard margins had slightly increased skin dose when compared to conventional linac plans. Using reduced margins alleviated this issue and decreased exposure of several other organs-at-risk (OAR). Reduced margins also enabled increased isotoxic target dose escalation.<br/> <strong>Conclusions:</strong> It is feasible to generate treatment plans for LA NSCLC patients on a 1.5 T MR-Linac. Margin reduction, facilitated by an envisioned MRI-guided workflow, enables increased OAR sparing and isotoxic target dose escalation for the respective treatment approaches.</p>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            

            
            
            Journal article
            </a>
            
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Publication</div>
          <div class="col-12 col-md-9">In <em>Radiotherapy and Oncology</em></div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    <div class="space-below"></div>

    <div class="article-style"><p>&nbsp;</p>
</div>

    




    






  
  
    
  
  








  </div>
</div>



<div class="container">
  <footer class="site-footer">
  

  <p class="powered-by">
    &copy; 2019 &middot; 

    Powered by the
    <a href="https://sourcethemes.com/academic/" target="_blank" rel="noopener">Academic theme</a> for
    <a href="https://gohugo.io" target="_blank" rel="noopener">Hugo</a>.

  </p>
</footer>

</div>


<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

    

    
    
    
    <script src="/js/mathjax-config.js"></script>
    

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.3.1/jquery.min.js" integrity="sha512-+NqPlbbtM1QqiK8ZAo4Yrj2c4lNQoGv8P79DPtKzj++l5jnN39rHA/xsqn8zE9l0uSoxaCdrOgFs6yjyfbBxSg==" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js" integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/4.1.3/js/bootstrap.min.js" integrity="sha256-VsEqElsCHSGmnmHXGQzvoWjWwoznFSZc6hs7ARLRacQ=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js" integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.js" integrity="sha256-X5PoE3KU5l+JcX+w09p/wHl9AzK333C4hJ2I9S5mD4M=" crossorigin="anonymous"></script>

      
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/highlight.min.js" integrity="sha256-/BfiIkHlHoVihZdc6TFuj7MmJ0TWcWsMXkeDFwhi0zw=" crossorigin="anonymous"></script>
        
      

      
      
      <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.4/MathJax.js?config=TeX-AMS_CHTML-full" integrity="sha256-GhM+5JHb6QUzOQPXSJLEWP7R73CbkisjzK5Eyij4U9w=" crossorigin="anonymous" async></script>
      
    

    
    

    
    
    

    
    
    <script>hljs.initHighlightingOnLoad();</script>
    

    

    
    

    

    
    

    
    

    
    
    
    
    
    
    
      
    
    
    
    
    <script src="/js/academic.min.76a41a243fcea75defe7d35a07d3aaa3.js"></script>

  </body>
</html>

